Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study.
Giuseppina MieleSimone CepparuloGianmarco AbbadessaLuigi LavorgnaMaddalena SparacoVittorio SimeonLorenzo GuizzaroSimona BonavitaPublished in: Journal of clinical medicine (2023)
No associations between infections and relapses were observed, likely suggesting that disease-modifying therapies may protect against the risk of relapse potentially triggered by infections.
Keyphrases